Graft-versus-host reaction in small bowel transplantation and possibilities for its circumvention.
To describe GVHR in small bowel transplantation and its underlying mechanisms and to find methods for circumventing that response, accessory small bowel transplantation was carried out in the rat model. Animals not treated with cyclosporine, irradiation, or removal of the mesenteric lymph nodes of the graft died within 22 days postoperatively due to graft versus host disease. Mesenteric lymph nodes of the graft and recipient spleen and peripheral lymph nodes showed strong immunologic stimulation histologically and high antihost T-cell-mediated cytotoxic antihost reactivity. Seventy-one percent of the animals that had received 15 mg of cyclosporine per kilogram body weight orally survived 150 days after transplantation. After donor irradiation with 50 rads, 77 percent of the recipients survived 120 days. After microsurgical removal of the mesenteric lymph nodes of the graft, 89 percent survived 120 days. We conclude that GVHR plays an important role in small bowel transplantation and that the experimental regimens of donor, graft, and recipient treatment described herein have proved their efficacy for circumventing GVHR.
D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D004195:Disease Models, Animal; D006087:Graft vs Host Reaction; D007421:Intestine, Small / Q000276:immunology / Q000528:radiation effects / Q000637:transplantation*; D008198:Lymph Nodes / Q000637:transplantation; D008643:Mesentery; D008866:Microsurgery; D011183:Postoperative Complications; D051381:Rats; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D003524:Cyclosporins